The Enterprise Value as of November 2025 (TTM) for Boston Therapeutics, Inc. (BTHE) is 4.83M

According to Boston Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.83M. This represents a change of -34.05% compared to the average of 7.32M of the last 4 quarters.

Boston Therapeutics, Inc. (BTHE) Historical Enterprise Value (quarterly & annually)

How has BTHE Enterprise Value performed in the past?

The mean historical Enterprise Value of Boston Therapeutics, Inc. over the last ten years is 1.66M. The current 4.83M Enterprise Value has changed 29.04% with respect to the historical average. Over the past ten years (40 quarters), BTHE's Enterprise Value was at its highest in in the June 2021 quarter at 8.01M. The Enterprise Value was at its lowest in in the September 2013 quarter at -3603297.85.

Boston Therapeutics, Inc. (BTHE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Boston Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Boston Therapeutics, Inc. (BTHE) Average Enterprise Value

How has BTHE Enterprise Value performed in the past?

The current Enterprise Value of Boston Therapeutics, Inc. (BTHE) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Boston Therapeutics, Inc. (BTHE) Enterprise Value vs. Peers

How is BTHE’s Enterprise Value compared to its peers?

Boston Therapeutics, Inc.’s Enterprise Value is greater than Bionomics Limited (-5324943.00), less than Tetra Bio-Pharma Inc. (8.81M), less than Immune Therapeutics, Inc. (8.32M), less than MDxHealth S.A. (236.80M), less than The Flowr Corporation (29.54M), less than Polydex Pharmaceuticals Limited (7.95M), greater than Forward Pharma A/S (-63324300.00), less than Living Cell Technologies Limited (21.43M), greater than HealthBeacon plc (-4215983.68), less than Avecho Biotechnology Limited (17.86M),

Build a custom stock screener for Boston Therapeutics, Inc. (BTHE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boston Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Boston Therapeutics, Inc. (BTHE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Boston Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.